Sinochem's pharmaceutical chemical business comprises of R&D, manufacturing, and distribution, pursuing advanced technologies and high-end market. Over years, we have established unique competitive advantage in the fields of medical equipment, nutrition and health product raw materials, and pharmaceutical safety evaluation.
Research Institute of Biotechnology and Medicine affiliated to Shenyang Research Institute of Chemical Industry is mainly engaged in the research and development of anti-cancer and anti-infective drugs. The first innovative small molecule compound SYD007 closes the vacuum of the absence of bladder infusion medicines in China. The Safety Evaluation Center of Shenyang Research Institute of Chemical Industry is the first organization in China to pass the GLP certification of an OECD member. The Center is qualified to conduct one-stop pharmaceutical safety evaluation test.